Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Zon

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Pharmaceutical Research|September 1, 1988
Oligonucleotide analogues as potential chemotherapeutic agentsG Zon
Molecular Neurobiology|April 1, 1995
Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications. Prospects for neurobiologyG Zon
Toxicology Letters|December 1, 1995
Antisense phosphorothioate oligodeoxynucleotides: introductory concepts and possible molecular mechanisms of toxicityG Zon
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1993
Oligonucleoside phosphorothioatesG Zon
Annals of the New York Academy of Sciences|January 1, 1990
Innovations in the use of antisense oligonucleotidesG Zon
Progress in Medicinal Chemistry|January 1, 1982
Cyclophosphamide analoguesG Zon
Annals of the New York Academy of Sciences|October 28, 1992
Separation of synthetic phosphorothioate oligonucleotides from phosphodiester-defect species by strong-anion exchange HPLCB J Bergot, G Zon
Anti-Cancer Drug Design|December 1, 1991
Phosphorothioate oligonucleotides: chemistry, purification, analysis, scale-up and future directionsG Zon, T G Geiser
Journal of Medicinal Chemistry|December 1, 1975
Synthesis and antitumor activity of cyclophosphamide analogs. 1. Benzo annulated cyclophosphamide and related systemsS M Ludeman, G Zon
Current Opinion in Molecular Therapeutics|November 21, 2001
Preclinical and clinical experience of antisense therapy for solid tumorsM S Webb, G Zon
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Pharmaceutical Research|September 1, 1988
Oligonucleotide analogues as potential chemotherapeutic agentsG Zon
Molecular Neurobiology|April 1, 1995
Brief overview of control of genetic expression by antisense oligonucleotides and in vivo applications. Prospects for neurobiologyG Zon
Toxicology Letters|December 1, 1995
Antisense phosphorothioate oligodeoxynucleotides: introductory concepts and possible molecular mechanisms of toxicityG Zon
Methods in Molecular Biology (Clifton, N.J.)|January 1, 1993
Oligonucleoside phosphorothioatesG Zon
Annals of the New York Academy of Sciences|January 1, 1990
Innovations in the use of antisense oligonucleotidesG Zon
Progress in Medicinal Chemistry|January 1, 1982
Cyclophosphamide analoguesG Zon
Annals of the New York Academy of Sciences|October 28, 1992
Separation of synthetic phosphorothioate oligonucleotides from phosphodiester-defect species by strong-anion exchange HPLCB J Bergot, G Zon
Anti-Cancer Drug Design|December 1, 1991
Phosphorothioate oligonucleotides: chemistry, purification, analysis, scale-up and future directionsG Zon, T G Geiser
Journal of Medicinal Chemistry|December 1, 1975
Synthesis and antitumor activity of cyclophosphamide analogs. 1. Benzo annulated cyclophosphamide and related systemsS M Ludeman, G Zon
Current Opinion in Molecular Therapeutics|November 21, 2001
Preclinical and clinical experience of antisense therapy for solid tumorsM S Webb, G Zon
Pageof 15